Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed vs Immediate Docetaxel in Advanced NSCLC
NCT00074204Phase 3Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Oct 2003
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Case Comprehensive Cancer Center. Started Oct 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00074204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074204.